84 related articles for article (PubMed ID: 28378635)
21. The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation.
Yazdani Y; Farazmandfar T; Azadeh H; Zekavatian Z
J Biomed Sci; 2016 Jan; 23():9. PubMed ID: 26787105
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level.
Rhee YY; Kim MJ; Bae JM; Koh JM; Cho NY; Juhnn YS; Kim D; Kang GH
Ann Surg Oncol; 2012 Oct; 19(11):3441-8. PubMed ID: 22618722
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors.
Kamimae S; Yamamoto E; Kai M; Niinuma T; Yamano HO; Nojima M; Yoshikawa K; Kimura T; Takagi R; Harada E; Harada T; Maruyama R; Sasaki Y; Tokino T; Shinomura Y; Sugai T; Imai K; Suzuki H
Oncotarget; 2015 Oct; 6(30):29975-90. PubMed ID: 26334593
[TBL] [Abstract][Full Text] [Related]
24. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of methylation of CpG island in cystathionine beta synthase promoter and clinicopathological features in colorectal cancer].
Tu XH; Huang SX; Li WS; Song JX
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):351-5. PubMed ID: 24054011
[TBL] [Abstract][Full Text] [Related]
26. WNT5A gene is aberrantly methylated from the early stages of colorectal cancers.
Hibi K; Mizukami H; Goto T; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Hepatogastroenterology; 2009; 56(93):1007-9. PubMed ID: 19760930
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis.
Chen J; Röcken C; Lofton-Day C; Schulz HU; Müller O; Kutzner N; Malfertheiner P; Ebert MP
Carcinogenesis; 2005 Jan; 26(1):37-43. PubMed ID: 15375009
[TBL] [Abstract][Full Text] [Related]
29. Methylation of CDX2 as a Predictor in Poor Clinical Outcome of Patients with Colorectal Cancer.
Jiang G; Luo C; Sun M; Zhao Z; Li W; Chen K; Fan T
Genet Test Mol Biomarkers; 2016 Nov; 20(11):710-714. PubMed ID: 27754705
[TBL] [Abstract][Full Text] [Related]
30. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
[TBL] [Abstract][Full Text] [Related]
31. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
32. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
[TBL] [Abstract][Full Text] [Related]
33. Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer.
Kohonen-Corish MR; Sigglekow ND; Susanto J; Chapuis PH; Bokey EL; Dent OF; Chan C; Lin BP; Seng TJ; Laird PW; Young J; Leggett BA; Jass JR; Sutherland RL
Oncogene; 2007 Jun; 26(30):4435-41. PubMed ID: 17260021
[TBL] [Abstract][Full Text] [Related]
34. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
35. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
36. Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.
Li C; Cai S; Wang X; Jiang Z
PLoS One; 2014; 9(11):e112005. PubMed ID: 25375219
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic target.
Scartozzi M; Bearzi I; Mandolesi A; Galizia E; Pierantoni C; Loupakis F; Berardi R; Zaniboni A; Quadri A; Zorzi F; Biagetti S; Loretelli C; Biscotti T; Labianca R; Masi G; Falcone A; Cascinu S
Anal Quant Cytol Histol; 2009 Dec; 31(6):417-23. PubMed ID: 20698358
[TBL] [Abstract][Full Text] [Related]
38. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
39. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
[TBL] [Abstract][Full Text] [Related]
40. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.
Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2008; 28(3A):1581-4. PubMed ID: 18630515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]